Business Context and Reporting Period
Mannatech, Incorporated (MTEX) is a global wellness solution provider operating as a single reporting segment. The company develops and sells proprietary nutritional supplements, skin care, anti-aging, and weight-management products primarily through a network marketing distribution channel. The company operates in three regions: the Americas, Europe/Middle East/Africa (EMEA), and Asia/Pacific. This filing covers the fiscal year ended December 31, 2025.
Key Financial Metrics
| Metric | 2025 | 2024 |
|---|---|---|
| Net Sales | $108.0 million | $117.9 million |
| Gross Profit | $81.0 million (74.9% margin) | $91.5 million (77.6% margin) |
| Operating Income (Loss) | ($0.4 million) | $1.4 million |
| Net Income (Loss) | ($15.2 million) | $2.5 million |
| Diluted EPS | ($8.00) | $1.32 |
| Cash and Cash Equivalents | $6.2 million | $11.4 million |
| Working Capital | $1.8 million | $5.2 million |
| Debt (Notes Payable) | $2.8 million | $3.0 million |
Note: The 2025 Net Loss includes approximately $12.3 million in non-cash income tax charges, primarily driven by a $9.7 million deferred tax liability on unremitted foreign earnings and a $1.7 million valuation allowance adjustment.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 8.3% year-over-year. On a constant dollar basis, sales declined 6.8%, with unfavorable foreign exchange contributing an additional $1.9 million decrease.
- Associate Base Contraction: Active associates and preferred customers dropped from 133,000 in 2024 to 114,000 in 2025 (a 14.3% decline).
- Regional Performance:
- Americas: Sales decreased 18.1% to $32.5 million.
- Asia/Pacific: Sales decreased 3.8% to $66.4 million (Republic of Korea remains the largest market).
- EMEA: Sales decreased 1.1% to $9.1 million.
- Operating Loss: The company shifted from operating income of $1.4 million in 2024 to an operating loss of $0.4 million in 2025.
- System Disruption: Management reported an estimated revenue loss of over $6.0 million in 2025 due to order processing system issues in North America.
Guidance, Outlook, Risks, and Contingencies
Going Concern Uncertainty
The filing explicitly states that substantial doubt exists regarding the Company's ability to continue as a going concern for the twelve-month period following the issuance of the report. This is due to declining net sales, operating losses, and negative cash flows from operations ($3.0 million used in 2025).
Management Actions
- Cost Reduction: Implementation of a comprehensive cost reduction plan, including headcount reductions and suspension of non-essential capital expenditures for 2026.
- Director Compensation: Effective April 1, 2026, directors may elect to receive retainers in stock rather than cash, expected to preserve approximately $0.8 million annually.
- Margin Improvement: Targeted price increases and supply chain optimization.
Key Risks
- Liquidity: Reliance on cash flows from operations to fund business; potential need for external capital injection.
- Regulatory: Ongoing scrutiny of network marketing models by the FTC and international regulators; potential changes to earnings claim rules.
- Supply Chain: Dependence on third-party manufacturers and single-source suppliers for key ingredients (e.g., Arabinogalactan).
- Associate Retention: Heavy reliance on independent associates for sales; loss of key leaders could materially impact revenue.
Investor Verification Checklist
- Cash Runway: Verify the sufficiency of the $6.2 million cash balance against the $3.0 million operating cash burn rate and fixed obligations.
- Non-Cash Tax Charges: Confirm the impact of the $12.3 million tax charge on future cash tax liabilities versus balance sheet adjustments.
- Associate Trends: Monitor the 14.3% decline in the active associate base and the effectiveness of new recruitment incentives.
- System Remediation: Assess the resolution of the North American order processing issues that caused an estimated $6.0 million revenue loss.
- Debt Maturity: Review the terms of the $2.8 million in related-party notes payable, recently extended to September 2027.